Top Abstract Purchase Related
Home
>
Node
>
Subnode

The lymphomas: molecular pathways and novel therapeutic targets

Wedgwood, A.; Pro, B.; Younes, A.

Current Hematology Reports 4(4): 324-334

2005

ISSN/ISBN: 1541-0714
PMID: 16009048
Document Number: 591053
In recent years, several molecular mechanisms involved in promoting cancer cell survival and growth have been identified. These discoveries helped in designing and testing novel drugs that target specific cellular pathways. In this review, we focus on new molecular targets that are currently being explored for the treatment of non-Hodgkin's lymphoma and Hodgkin's lymphoma.

Document emailed within 1 workday
Secure & encrypted payments

Tsuji, D.; Itoh, K. 2007: Molecular pathogenesis and therapeutic targets of lysosomal diseases Seikagaku. Journal of Japanese Biochemical Society 79(7): 678-682
Herber, D.L. 2007: Molecular Targets in Cancer Therapy - Fourth Biennial Meeting. Mechanism and therapeutic reversal of immune suppression in cancer IDrugs: the investigational drugs journal 10(4): 227-229
Gao, G.; Xu, J. 2013: Important biology events and pathways in Brucella infection and implications for novel antibiotic drug targets Critical Reviews in Eukaryotic Gene Expression 23(1): 65-76
De Almagro, M.C.; Vucic, D. 2012: The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy Experimental Oncology 34(3): 200-211
Gorman, J.M. 2003: New molecular targets for antianxiety interventions Journal of Clinical Psychiatry 64(Suppl 3): 28-35
Coleman, R. 2018: Setting the scene, setting the targets. The Joint United Nations Programme on HIV/AIDS prevention targets of 2016 and estimating global pre-exposure prophylaxis targets Sexual Health 15(6): 485-488
Bogush, T.A.; Dudko, E.A.; Bogush, E.A.; Polotskiĭ, B.E.; Tiuliandin, S.A.; Davydov, M.I. 2012: Tamoxifen molecular targets different from estrogen receptors Antibiotiki i Khimioterapiia 57(1-2): 50-58
Santoro, F.; Vassena, L.; Lusso, P. 2004: Chemokine receptors as new molecular targets for antiviral therapy New Microbiologica 27(2 Suppl 1: 17-29
Cotter, F.E. 1993: Molecular pathology of lymphomas Cancer Surveys 16: 157-174
Mitsudomi, T. 2002: Molecular lesions as targets for diagnosis and therapy of lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(Suppl 1): 112-116
Sterlinko Grm, H.; Banks, L. 2004: HPV proteins as targets for therapeutic intervention Antiviral Therapy 9(5): 665-678
Bogush, T.A.; Polezhaev, B.B.; Dudko, E.A.; Bogush, E.A.; Kirsanov, V.Y.; Polotsky, B.E.; Tjuljandin, S.A.; Davydov, M.I. 2016: New Data on Molecular Targets of Tamoxifen Besides Estrogen Receptors, their Clinical Significancy Antibiotiki i Khimioterapiia 61: 41-49
Garvey, R. 2006: AACR-NCI-EORTC--17th Symposium: Molecular Targets and Cancer Therapeutics IDrugs: the investigational drugs journal 9(2): 90-92
Scholl, S.M. 2001: Molecular targets and cancer therapeutics: discovery, biology and clinical applications Idrugs: the Investigational Drugs Journal 4(12): 1357-1360
Pao, L.I.; Bedzyk, W.D.; Persin, C.; Cambier, J.C. 1997: Molecular targets of CD45 in B cell antigen receptor signal transduction Journal of Immunology 158(3): 1116-1124
Burns, P.A.; Balmain, A. 1992: Potential therapeutic targets in multistep oncogenesis Seminars in Cancer Biology 3(6): 335-341
Luján-Miras, R. 2005: Metabotropic glutamate receptors: new molecular targets in the treatment of neurological and psychiatric diseases Revista de Neurologia 40(1): 43-53
Chen, S.-z. 2016: Research progress in anticancer effects and molecular targets of honokiol in experimental therapy Yao Xue Xue Bao 51(2): 202-207
Collins, T. 2007: AACR-NCI-EORTC--19th symposium. Molecular Targets and Cancer Therapeutics--Part 3 IDrugs: the investigational drugs journal 10(12): 840-843
Ariazi, E.A.; Ariazi, J.L.; Cordera, F.; Jordan, V.C. 2006: Estrogen receptors as therapeutic targets in breast cancer Current Topics in Medicinal Chemistry 6(3): 181-202